Ceftazidime-avibactam versus ceftolozane-tazobactam in the treatment of drug-resistant Pseudomonas aeruginosa: a meta-analysis
Our meta-analysis indicated that CA and CT demonstrated comparable clinical outcomes for the treatment of infection caused by resistant P. aeruginosa. However, limitations of the included studies should be acknowledged. More data are needed to validate these findings.
Authors
- Yazed Saleh Alsowaida (ORCID: https://orcid.org/0000-0002-0450-9846)
- Abdullah A. Alhifany (ORCID: https://orcid.org/0000-0001-9492-9483)
- Leen Ghonem (ORCID: https://orcid.org/0000-0001-8850-1384)
- Essam A. Tawfik (ORCID: https://orcid.org/0000-0003-0716-3251)
- Sulaiman Alzunaydi
- Shahd Mohammad
- Aisha Alshahwan
- Felwah AlManea
- Mohammed Alessa
Institutions
- King Abdulaziz City for Science and Technology (SA)
- King Saud Medical City (SA)
- Shaikh Khalifa Medical City (AE)
- King Saud University (SA)
- University of Ha'il (SA)
Publication Details
- Journal
- International Journal of Infectious Diseases
- Published
- 2026-02-14
- DOI
- https://doi.org/10.1016/j.ijid.2026.108485
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- King Saud University